Booth No.5P-22
CategoryOutsourcing
OBIGEN PHARMA, Inc.
Booth No.：5P-22
Category：Outsourcing
Company Information
Email：
contactus@obigenpharma.com
TEL： +886-975-716-271
Address： 115011
7F.-1, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist. TAIWAN URL： https://www.obigenpharma.com/en
7F.-1, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist. TAIWAN URL： https://www.obigenpharma.com/en
Contact in Japan
Japan agent： Obigen Pharma, Inc.
Established in 2020, OBIGEN Pharma is the first biotechnology startup in Taiwan specializing in the research, development, production, and manufacturing of type A Botulinum toxin, OBI-858, the first 760kDa molecular structure patented in five countries. Owning an API plant that meets the PIC/s GMP standards and a high-security sterile drug product plant, OBIGEN PHARMA develops stable quality products, actively forging partnerships to launch the exceptional Taiwan toxin globally to advance the entire medical industry together.
Company information
| Address | 115011 7F.-1, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist. TAIWAN |
|---|---|
| TEL | +886-975-716-271 |
| URL | https://www.obigenpharma.com/en |
| contactus@obigenpharma.com |
| Product Classification |
OBI-858, 760kDa Twain botulinum toxin type A |
|---|
Contact in Japan
| Japan Agent | Obigen Pharma, Inc. |
|---|
Product introduction
OBI-858, 760kDa Twain botulinum toxin type A